Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results

BEIJING, Dec. 3, 2025 /PRNewswire/ — Waterdrop Inc. (“Waterdrop”, the “Company” or “we”) (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the three and nine months…

FX Junction Redefines Social Trading

ZURICH, Dec. 3, 2025 /PRNewswire/ — The investment and trading platform FX Junction has surpassed 40,000 users, placing it among the world’s leading social trading networks. In the area of CFDs and forex, FX Junction had already established itself as one of the global leaders among…

Synergy ECP Acquires Federal IT Solutions Leader NetServices

COLUMBIA, Md., Dec. 3, 2025 /PRNewswire/ — Synergy ECP, a provider of software engineering, cybersecurity, and systems engineering services for the U.S. Intelligence and Defense communities, today announced its acquisition of NetServices, a premier provider of secure, innovative…

Ultrasound Pinpoints Vascular Complications from Cosmetic Fillers

CHICAGO, Dec. 3, 2025 /PRNewswire/ — Ultrasound can aid in treating complications from cosmetic filler injections, according to research being presented this week at the annual meeting of the Radiological Society of North America (RSNA). Cosmetic fillers are injectable substances used to…

Formosa Pharmaceuticals Announces Licensing Agreement with Rxilient, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

TAIPEI, Dec. 3, 2025 /PRNewswire/ — Taiwan-based Formosa Pharmaceuticals (“Formosa”, 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Rxilient Medical Pte. Ltd. (“Rxilient”), for exclusive rights to the commercialization of clobetasol…